Sexual behavior and pregnancy outcome in HIV-infected women

被引:30
作者
Hankins, C
Tran, T
Lapointe, N
机构
[1] Montreal Reg Publ Hlth Dept, Infect Dis Unit, Montreal, PQ H3H 1P8, Canada
[2] McGill Univ, McGill Aids Ctr, Montreal, PQ, Canada
[3] McGill Univ, Dept Epidemiol & Biostat, Montreal, PQ, Canada
[4] Univ Montreal, Hop St Justine, Ctr Maternel & Infantile, SIDA, Montreal, PQ H3T 1C5, Canada
来源
JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY | 1998年 / 18卷 / 05期
关键词
HIV; AIDS; women; sexual behavior; pregnancy; contraception; therapeutic abortion;
D O I
10.1097/00042560-199808150-00010
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Sexual behavior and pregnancy outcome data for 392 HIV-infected women were analyzed. During the 6 months before study entry, 71.2% (279 of 392 women) were sexually active. In multivariate regression, women with baseline CD4(+) greater than or equal to 200/mu l were more likely than women with CD4(+) <200/mu l to be sexually active (adjusted odds ratio [OR] = 1.75; 95% confidence interval [CI], 1.06-2.88; p = .03). Consistent condom use was reported with 58.4% (149 of 255) of steady male partners and 65.7% (23 of 35) of casual partners. Overall, 90.3% of 279 sexually active women were using contraception. Among women aged between 15 and 44 years (n = 320), the incidence of pregnancy in the year before HIV diagnosis was 27.5 per 100 person-years (PY) (95% CI, 22.1-33.9) compared with 8.3/100 PY (95% CI, 6.8-10.2) in the time since HIV diagnosis (p < .001). The incidence of therapeutic termination of pregnancies conceived in the 20 weeks before HIV diagnosis (10.6/100 PY) was more than triple that after diagnosis (3.1/100 PY; p = .001). After publication of results of zidovudine prophylaxis of mother-to-child transmission, pregnancy rates did not increase, but the incidence of therapeutic abortion dropped from 4.3/100 PY to 1.4/100 PY (p = .009). Knowledge of sexual behavior, including pregnancy frequency and outcome, can assist in tailoring counseling for HIV-infected women concerning sexual and reproductive health.
引用
收藏
页码:479 / 487
页数:9
相关论文
共 28 条
[1]  
[Anonymous], PROGRAMME MED PRESCR
[2]  
BROWN G, 1991, BIOPS ASP HIV INF 1, P21
[3]   PROSPECTIVE-STUDY OF PSYCHIATRIC MORBIDITY IN HIV-SEROPOSITIVE WOMEN WITHOUT AIDS [J].
BROWN, GR ;
RUNDELL, JR .
GENERAL HOSPITAL PSYCHIATRY, 1990, 12 (01) :30-35
[4]  
*CAN CTR SUBST AB, 1997, HIV AIDS INJ DRUG US
[5]  
CHUNG JY, 1992, HOSP COMMUNITY PSYCH, V43, P891
[6]   Contraceptive and sexually transmitted diseases protection among adult and adolescent women infected with human immunodeficiency virus [J].
Clark, RA ;
Kissinger, P ;
Williams, T .
INTERNATIONAL JOURNAL OF STD & AIDS, 1996, 7 (06) :439-442
[7]   Determination of factors associated with condom use among women infected with human immunodeficiency virus [J].
Clark, RA ;
Kissinger, P ;
Bedimo, AL ;
Dunn, P ;
Albertin, H .
INTERNATIONAL JOURNAL OF STD & AIDS, 1997, 8 (04) :229-233
[8]   REDUCTION OF MATERNAL-INFANT TRANSMISSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH ZIDOVUDINE TREATMENT [J].
CONNOR, EM ;
SPERLING, RS ;
GELBER, R ;
KISELEV, P ;
SCOTT, G ;
OSULLIVAN, MJ ;
VANDYKE, R ;
BEY, M ;
SHEARER, W ;
JACOBSON, RL ;
JIMENEZ, E ;
ONEILL, E ;
BAZIN, B ;
DELFRAISSY, JF ;
CULNANE, M ;
COOMBS, R ;
ELKINS, M ;
MOYE, J ;
STRATTON, P ;
BALSLEY, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (18) :1173-1180
[9]   Pregnancy and contraception in a French cohort of HIV-infected women [J].
DeVincenzi, I ;
Jadand, C ;
Couturier, E ;
Brunet, JB ;
Gallais, H ;
Gastaut, JA ;
Goujard, C ;
Deveau, C ;
Meyer, L ;
Rouzioux, C ;
Bary, M ;
Burgard, M ;
Dormont, J ;
Delfraissy, JF ;
Levy, A ;
Boue, F ;
Dellamonica, P ;
Perbost, I ;
Carles, M ;
Mondain, V ;
Guillevin, L ;
Jarousse, B ;
Trogoff, B ;
Lebras, P ;
Quertainmont, Y ;
Vilde, JL ;
Leport, C ;
Colassante, U ;
Kazatchkine, M ;
Vellay, A ;
Buisson, M ;
Cassuto, JP ;
Reboulot, B ;
Sereni, D ;
Gomez, V ;
Bachmeyer, C ;
Mars, ME ;
Gallais, J ;
Sobel, A ;
Duval, J ;
Majerhole, C ;
Deforges, L ;
Lefrere, JJ ;
Lerable, J ;
Joubert, L ;
Dupont, B ;
Beuzelin, C ;
Fournier, S ;
Vittecoq, D ;
Bolliot, C .
AIDS, 1997, 11 (03) :333-338
[10]   THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].
FAHEY, JL ;
TAYLOR, JMG ;
DETELS, R ;
HOFMANN, B ;
MELMED, R ;
NISHANIAN, P ;
GIORGI, JV .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :166-172